Press Release

Myomo Announces First Adolescent Patients to be Fitted with MyoPro

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo, Inc., a wearable medical robotics company, has achieved recent momentum fitting and delivering MyoPro to adolescent users. Approved to assist young adults suffering from any disease or injury leaving them with a paralyzed or weakened arm, MyoPro is restoring motion and functionality to adolescents with conditions such as cerebral palsy, brachial plexus…

Read More

Myomo® Receives Medicare Codes

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo,” or the “Company”), a wearable medical robotics company, announces that the Centers for Medicare & Medicaid Services (“CMS”) has published two new codes pursuant to the Company’s application for Healthcare Common Procedure Coding System (HCPCS) “L” codes. Myomo had filed its application in December 2017 to have…

Read More

Myomo Announces Third Quarter 2018 Financial Results

CAMBRIDGE, Mass., November 5, 2018 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today reports its financial results for the third quarter ended September 30, 2018. Read more.

Read More

Myomo to Report Third Quarter 2018 Results on November 5, 2018

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company, today announced that it will release its financial results for the third quarter 2018 on Monday, November 5, 2018, after the US markets close. Read more.

Read More

Myomo to Present at The MicroCap Conference

Cambridge, MA., September 18, 2018/ ACCESSWIRE – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it will be presenting at The MicroCap Conference on Monday, October 1st at 11:00 AM EDT, Track…

Read More

Myomo Announces Continued Momentum Across Europe

CAMBRIDGE, Mass. September 12, 2018 Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company, today announced continued momentum across Europe with the appointment of John Frijters as Business Development Manager for EU, a distributor agreement with Bandagist Jan Nielsen to deliver MyoPro to patients across Denmark and the first screening day in the…

Read More

Myomo Announces Second Quarter 2018 Financial Results

CAMBRIDGE, Mass., August 7, 2018 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today reports its financial results for the second quarter ended June 30, 2018. Read more.

Read More

Myomo to Report Second Quarter 2018 Results on August 7, 2018

CAMBRIDGE, Mass., July 31, 2018 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company, today announced that it will release its financial results for the second quarter 2018 on Tuesday, August 7, 2018, after the US markets close. Read more.

Read More

Myomo Appoints Micah Mitchell as Chief Commercial Officer

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company, announced today that Micah Mitchell is joining the company as chief commercial officer (CCO), a newly created executive role. The addition of a CCO reflects Myomo’s transition from a controlled introduction of its proprietary MyoPro product line to expansion of…

Read More

Research Team Presents Promising Preliminary Results from TBI Study Using Myomo’s MyoPro

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Researchers from the Northwestern University Prosthetics-Orthotics Center (NUPOC) and the Cleveland VA Medical Center have presented promising preliminary case reports from a clinical trial that evaluates the effects of the MyoPro myoelectric arm orthosis (powered brace) from Myomo on traumatic brain injury (TBI) patients at the Cleveland VA Medical Center. Read more.

Read More